Stem Cell Therapy International, Inc.
Stem Cell Therapy International, Inc. (SCII) is a publicly traded company in the Unknown sector. Across all available filings, 4 corporate insiders have executed 7 transactions totaling $4.3K, demonstrating a bearish sentiment with -$2.3K in net insider flow. The most recent transaction on Sep 16, 2009 involved a sale of 5,000 shares valued at $1.6K.
SCII Insider Activity Summary
Who Is Buying SCII Stock?
No significant insider buying has been recorded for SCII in the recent period.
Who Is Selling SCII Stock?
No significant insider selling has been recorded for SCII in the recent period.
Is Stem Cell Therapy International, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for SCII is bearish with an Insider Alignment Score of 23/100 and a net flow of -$2.3K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
SCII Frequently Asked Questions
Understanding SCII Insider Activity
Insider trading at Stem Cell Therapy International, Inc. (SCII) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 4 insiders are actively trading SCII stock, having executed 7 transactions in the past 90 days. The most active insider is David Stark (Executive), who has made 3 transactions totaling $61.0K.
Related Tools
Track Stem Cell Therapy International, Inc. Insider Activity
Get notified when executives and directors at SCII file new Form 4 transactions